December 10, 2022Open Access

Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function

Key Points

Key points are not available for this paper at this time.

Abstract

Our work identifies GA as an important suppressor of NAFLD-HCC progression, and underscores the AMPK-ACC-PPARα signal axis as a potential therapeutic target for NAFLD treatment.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Zhang et al. (Sat,) studied this question.

synapsesocial.com/papers/69d7bb71e57cdc1cc9ae29df https://doi.org/https://doi.org/10.1016/j.phymed.2022.154589

Bookmark

View Full Paper